Pharmafile Logo
Pharmafocus logo
Advanced Search

bevacizumab

Showing 11 posts of 11 posts found.

Avastin image

EU nod for Roche cancer drug and chemotherapy

April 8, 2015
Sales and Marketing Cancer, Roche, avastin, bevacizumab, cervical, chemotherapy, wet AMD

The European Commission has approved Roche’s Avastin in combination with standard chemotherapy for women with advanced cervical cancer.  Avastin (bevacizumab) …

News
Lucentis image

Novartis accused of Lucentis ‘campaign’ against Avastin

April 2, 2015
Sales and Marketing Lucentis, NHS, Novartis, avastin, bevacizumab, ranibizumab, wet AMD

Novartis “embarked on a campaign to undermine and divert attention” from a cheap drug for vision loss and maintain the …

News
Avastin image

Doctors appeal to prescribe Avastin off-label

February 25, 2015
Sales and Marketing Lucentis, NHS, NICE, Novartis, Roche, bevacizumab, wet AMD

NHS Clinical Commissioners have called for the removal of barriers preventing CCGs from prescribing Roche’s Avastin to treat wet age-related …

News
Roche's Avastin (bevacizumab)

Avastin’s breast cancer use to continue in Europe

March 2, 2011
Sales and Marketing CHMP, Cancer, European Commission, Roche, avastin, bevacizumab, breast cancer, docetaxel, paclitaxel

Roche’s Avastin will remain on the market as a treatment for breast cancer, but only in combination with paclitaxel, the …

News
Roche's Avastin (bevacizumab)

NICE yes for Votrient, no to Avastin

February 23, 2011
Sales and Marketing Cancer, GSK, GlaxoSmithKline, Kidney cancer, NICE, Roche, avastin, bevacizumab, breast cancer

NICE has recommended GlaxoSmithKline’s kidney cancer drug Votrient on the same day it gave a final negative decision to Roche’s …

News

Roche eyes ovarian cancer expansion for Avastin

February 8, 2011
Sales and Marketing Cancer, Roche, avastin, bevacizumab, ovarian cancer

Roche has submitted an EU marketing authorisation for Avastin for the treatment of ovarian cancer and plans to file the …

News
Roche's Avastin (bevacizumab)

Survey shows doctors support FDA Avastin decision

February 7, 2011
Sales and Marketing FDA, Roche, Sermo, avastin, bevacizumab

A survey of US doctors suggests that a majority support the FDA’s decision to take away Avastin’s licence for use …

News
Avastin (bevacizumab) packs

Study highlights Avastin heart failure risk

January 6, 2011
Research and Development, Sales and Marketing Roche, avastin, bevacizumab, breast cancer

A new study confirms that Roche’s Avastin is linked to a small but significant increased risk of heart failure in …

News

Roche to challenge FDA on Avastin

December 21, 2010
Sales and Marketing EMA, FDA, Roche, avastin, bevacizumab, breast cancer

Roche is set to challenge the decision by the FDA to remove a breast cancer indication from its blockbuster drug …

News
Avastin packs

NICE no for Avastin in breast cancer

December 8, 2010
Sales and Marketing NICE, Roche, avastin, bevacizumab, breast cancer, health technology assessment, hta

NICE has refused to back Roche’s Avastin for use in breast cancer patients citing the blockbuster drug’s high cost and …

News
Avastin packs

NICE stands firm on Avastin rejection

November 12, 2010
Sales and Marketing NICE, Roche, avastin, bevacizumab, colon cancer, metastatic colorectal cancer, patient access scheme

NICE has refused to recommend Roche’s blockbuster cancer drug Avastin for the treatment of metastatic colorectal cancer in its final …

News

Latest content

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024

PeptiDream and Novartis extend peptide discovery collaboration

April 30, 2024

Pfizer’s Beqvez approved by FDA for haemophilia B treatment

April 29, 2024